-
Behavioral disorders and cognitive impairment associated with cerebellar lesions
-
Molecular Characterization of Cerebellar Dysplastic Gangliocytoma With Clinical and Radiological Correlations
-
Anti-Yo?associated paraneoplastic cerebellar degeneration revealing appendiceal adenocarcinoma: ...
-
Cerebellar structure and function abnormalities in 16p11.2 microduplication mice
-
Cerebellar Transcranial Alternating Current Stimulation in the Theta Band Prevents Recall of the Initial Fear Association After Extinction Training
-
Diagnostic Challenges of LRP4 Antibody Testing in Myasthenia Gravis: A Case Series of Four LRP4 Positive Cases With Uncertain Diagnostic Significance
-
Eosinophil Recruitment and Activity in CNS Lesions of MOG Antibody–Associated Myelitis Following Influenza Vaccination: A Case Report
-
Gene-specific response to muscle specific kinase agonist antibody in the treatment of congenital myasthenic syndromes
-
Transcranial Calcium Macro‐Imaging From the Auditory Cortex of Thy1‐Cre‐Driven GCaMP8 Transgenic Rats
-
Clinical Neuropsychiatry Volume 22, issue 6 – December 2025
-
The most popular topics in neuroscience over the past 6 months
-
Clinical Neuropsychiatry Volume 21, issue 6 – December 2024
-
Human herpesvirus 6A and other risk factors for multiple sclerosis
-
Toxic Effects of Excess Vitamins A, B6, and Folic Acid on the Nervous System
-
Peculiar Clinical Manifestation in a Child With Self-Limited Epilepsy With Autonomic Seizures (SeLEAS) Presenting in an All-Four Position: A Case Report
-
Peripheral Blood Regulatory T Cells and IL-6 are Associated with Cognitive Impairment After Acute Ischemic Stroke
-
Environmental unpredictability predicts positive social risk taking through neural cognitive control
-
Safety and Efficacy of Obinutuzumab β (MIL62), a Novel Glycoengineered Type II Anti-CD20 Monoclonal Antibody, in Patients with Neuromyelitis Optica Spectrum Disorder: A Multicenter, Single-Arm, Phase Ib Clinical Trial
-
Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results
-
Neurotrophin levels at admission did not change significantly upon alcohol deprivation and were positively correlated with the BMI and LDL levels
-
N-Glycosylation of mGluR6 Modulates Receptor Cell-Surface Transport, G-Protein Coupling, and Interactions With Synaptic Adhesion Molecules
-
Curcumin and an antioxidant formulation protect C57BL/6J mice from MPTP-induced Parkinson’s disease like changes: potential neuroprotection for neurodegeneration
-
Perampanel as add‐on in high‐grade glioma–related epilepsy: Seizure control and QoL in a prospective, multicenter, real‐world 6‐month follow‐up study
-
Correction: Genetic Evidence Supports a Potential Role of WTAP-related m6A Regulation in Vascular Dementia: Insights from Mendelian Randomization and Multi-omics Analyses
